Siga Technologies (SIGA) Receivables (2010 - 2025)
Siga Technologies (SIGA) posted Receivables of $3.3 million for Q4 2025, up 21.32% on a QoQ basis from $2.7 million in Q3 2025, and down 84.58% year-over-year from $21.2 million in Q4 2024.
Siga Technologies (SIGA) Receivables (2010 - 2025) Analysis & Trends
Siga Technologies' Receivables history runs 16 years deep, the most recent figure standing at $3.3 million for Q4 2025.
- Quarterly Receivables fell 84.58% year-over-year to $3.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.3 million (down 84.58% YoY) and the FY2025 annual result came in at $3.3 million, down 84.58% from the prior year.
- Receivables was $3.3 million for Q4 2025 at Siga Technologies, up from $2.7 million in the prior quarter.
- Across five years, Receivables topped out at $83.7 million in Q4 2021 and bottomed at $2.7 million in Q3 2025.
- A 5-year average of $19.9 million and a median of $14.9 million in 2023 frame the typical range for Receivables.
- Peak annual rise in Receivables reached 2404.31% in 2021, while the deepest fall reached 90.54% in 2021.
- Siga Technologies' Receivables stood at $83.7 million in 2021, then tumbled by 45.72% to $45.4 million in 2022, then slumped by 53.46% to $21.1 million in 2023, then climbed by 0.17% to $21.2 million in 2024, then plunged by 84.58% to $3.3 million in 2025.
- Business Quant data shows SIGA's Receivables at $3.3 million in Q4 2025, $2.7 million in Q3 2025, and $7.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 2.99 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 6.46 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 312.00 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.29 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.58 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 768.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.15 Bn |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | 3.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.26 Mn |
| Sep 30, 2025 | 2.69 Mn |
| Jun 30, 2025 | 7.19 Mn |
| Mar 31, 2025 | 8.09 Mn |
| Dec 31, 2024 | 21.17 Mn |
| Sep 30, 2024 | 14.89 Mn |
| Jun 30, 2024 | 17.65 Mn |
| Mar 31, 2024 | 34.93 Mn |
| Dec 31, 2023 | 21.13 Mn |
| Sep 30, 2023 | 14.95 Mn |
| Jun 30, 2023 | 9.83 Mn |
| Mar 31, 2023 | 17.42 Mn |
| Dec 31, 2022 | 45.41 Mn |
| Sep 30, 2022 | 54.93 Mn |
| Jun 30, 2022 | 19.60 Mn |
| Mar 31, 2022 | 5.34 Mn |
| Dec 31, 2021 | 83.65 Mn |
| Sep 30, 2021 | 3.82 Mn |
| Jun 30, 2021 | 7.21 Mn |
| Mar 31, 2021 | 4.00 Mn |